Skip to content
Sleep & circadian healthEvidence review3 min read

Long COVID: about 1 in 4 patients had depression or anxiety, and 45% had a sleep disorder

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis. · BMC psychiatry · 2024 · Original paper ↗

Key takeaway

Pooled across studies, 23% (95% CI 20%-26%) of people with post COVID-19 syndrome had depression and 23% (95% CI 20%-26%) had anxiety, while sleep disorder reached 45% (95% CI 37%-53%). Heterogeneity was extreme (I2 from 98.7% to 99.9%) and publication bias was possible, so these figures are a rough range, not a rate for any one group.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Long COVID, or post COVID-19 syndrome, covers symptoms that persist after recovery from infection, and mental health problems are among the most reported. Individual studies give widely different numbers. The authors pooled the global evidence to estimate how common depression, anxiety and sleep disorders are in people with long COVID.

Who and how

Systematic review and meta-analysis of original studies found by searching electronic databases up to 24 January 2023. Studies had to use previously validated assessment tools for depression, anxiety or sleep disorders and report prevalence, in patients of any age or region. A random effects model pooled prevalence, with subgroup analyses by region and assessment scale, meta-regression, and publication bias checks (Doi plot and Peters test).

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Pooled depression prevalence was 23% (95% CI 20%-26%; I2 = 99.9%) from 143 studies with 7,782,124 participants.
  2. 2
    Pooled anxiety prevalence was also 23% (95% CI 20%-26%; I2 = 99.9%) from 132 studies with 9,320,687 participants.
  3. 3
    Pooled sleep disorder prevalence was 45% (95% CI 37%-53%; I2 = 98.7%) from 27 studies with 15,362 participants.
  4. 4
    Prevalence varied significantly by geographic region and assessment scale. Meta-regression linked it to studies' total sample size, participants' age and the percentage of male participants.
  5. 5
    The Peters test suggested possible publication bias for depression (p = 0.0085) and sleep disorder (p = 0.02), but not anxiety (p = 0.11).

Limits & uncertainty

  1. 1
    I2 values of 98.7% to 99.9% mean the studies disagreed hugely, so one pooled percentage hides very different situations.
  2. 2
    Possible publication bias for depression and sleep disorder may distort the pooled figures.
  3. 3
    Studies used different questionnaires and scales, which the authors found changed prevalence; screening tools flag symptoms rather than confirm diagnoses.
  4. 4
    This reading is based on the abstract only, which does not give how long after infection people were assessed.

What to take from it

Low mood, anxiety and poor sleep are common among people living with long COVID, and they are worth raising rather than dismissing. These pooled percentages cannot predict your own risk. Anyone struggling with mood or sleep after an infection should talk with their clinician.

Reading your own data

Sleep duration and timing from a wearable can help you notice whether sleep is drifting after an illness, which is useful information to bring to a clinician. Wearable sleep stages and scores are estimates and cannot diagnose a sleep disorder, depression or anxiety, so compare your own multi-week trends on the same device.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Post COVID-19 syndrome, also known as "Long COVID," is a complex and multifaceted condition that affects individuals who have recovered from SARS-CoV-2 infection. This systematic review and meta-analysis aim to comprehensively assess the global prevalence of depression, anxiety, and sleep disorder in individuals coping with Post COVID-19 syndrome.

Methods

A rigorous search of electronic databases was conducted to identify original studies until 24 January 2023. The inclusion criteria comprised studies employing previously validated assessment tools for depression, anxiety, and sleep disorders, reporting prevalence rates, and encompassing patients of all age groups and geographical regions for subgroup analysis Random effects model was utilized for the meta-analysis. Meta-regression analysis was done.

Results

The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%-26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants and 132 studies with 9,320,687 participants, respectively. The pooled prevalence of sleep disorder among these patients, derived from 27 studies with 15,362 participants, was estimated to be 45% (95% CI: 37%-53%; I2 = 98.7%). Subgroup analyses based on geographical regions and assessment scales revealed significant variations in prevalence rates. Meta-regression analysis showed significant correlations between the prevalence and total sample size of studies, the age of participants, and the percentage of male participants. Publication bias was assessed using Doi plot visualization and the Peters test, revealing a potential source of publication bias for depression (p = 0.0085) and sleep disorder (p = 0.02). However, no evidence of publication bias was found for anxiety (p = 0.11).

Conclusion

This systematic review and meta-analysis demonstrate a considerable burden of mental health issues, including depression, anxiety, and sleep disorders, among individuals recovering from COVID-19. The findings emphasize the need for comprehensive mental health support and tailored interventions for patients experiencing persistent symptoms after COVID-19 recovery.

Sources & attribution

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis.

Seighali N, Abdollahi A, Shafiee A, Amini MJ, Teymouri Athar MM, Safari O, Faghfouri P, Eskandari A, Rostaii O, Salehi AH, Soltani H, Hosseini M, Abhari FS, Maghsoudi MR, Jahanbakhshi B, Bakhtiyari M.

BMC psychiatry · 2024-02-06

DOI: 10.1186/s12888-023-05481-6 ↗PubMed · 38321404 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →